Group 1 - Akoustis Technologies, Inc. is preparing to go public on NASDAQ, planning to offer 17.65 million shares priced between $16 and $18 to raise substantial capital [1] - Akoustis specializes in advanced RF filter solutions for the wireless industry, positioning itself to compete with major firms like Qorvo and Broadcom [1] - Aktis Oncology has successfully priced its upsized IPO at $18 per share, raising approximately $318 million, offering a similar share volume as Akoustis [2] Group 2 - Aktis Oncology's IPO is set to begin trading on the Nasdaq Global Select Market under the ticker symbol "AKTS" on January 9, 2026, with the offering expected to close on January 12, 2026 [3] - The current stock price for NASDAQ:AKTS is $0.03, reflecting a 100% increase, with a market capitalization of approximately $5.76 million and a trading volume of 74,784,722 shares [4]
Akoustis Technologies, Inc. and Aktis Oncology Prepare for Their Public Debuts